UPDATE: Stifel is Positive on Repare Therapeutics (RPTX) Ahead of RP-3500 Data for ATM and BRCA Patients
Tweet Send to a Friend
(Updated - November 11, 2021 6:46 AM EST)
Stifel analyst Benjamin J. Burnett maintains coverage on Repare Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Stifel analyst Benjamin J. Burnett maintains coverage on Repare Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
